← Leaderboards
Christopher Case
Leidos Biomedical Research, Inc.
$10,132,080
Attributed
$10,132,080
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6M · FY2015–22$10M$7.5M$5M$2.5M$0
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$10,132,080 · 2
By mechanism
N01$10,132,080 · 2
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- David Heimbrook$2,362,140,846
- Beth Baseler$335,223,481
- John Beigel$72,591,959
- Elizabeth Baseler$40,046,035
- Calvin Proffitt$24,262,802
Others in their field
Top investigators on “Immune Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
- Barton F Haynes · Duke University$456,664,915
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665
Research focus
Immune ResponseVaccinesCause Of DeathInfectionResponseVaccine CandidatePreventImmuneAntigensImmunizationImmunityAttenuatedRouteResearch StudyResearch Clinical TestingMonoclonal AntibodiesMissionNational Institute Of Allergy And Infectious DiseaseAntibodiesMalariaIntravenousCommunicable DiseasesPathogenBiological Markers
Grant awards (7)
NIAID - VRC - Pre-Clinical Assessment of monoclonal antibodies and other promising vaccines/agents$2,198,288
N01 · FY2022 · AI · contact PI
NIAID- VRC - PREMISE - Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology$1,000,000
N01 · FY2022 · AI · contact PI
NIAID- VRC - PREMISE - Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology$880,000
N01 · FY2022 · AI · contact PI
MALARIA VACCINE EVALUATION$72,404
N01 · FY2018 · CA · contact PI
TUBERCULOSIS VACCINE DEVELOPMENT$29,551
N01 · FY2018 · CA · contact PI
MALARIA VACCINE EVALUATION$3,951,837
N01 · FY2015 · CA · contact PI
TUBERCULOSIS VACCINE DEVELOPMENT$2,000,000
N01 · FY2015 · CA · contact PI